San Francisco, 12 February 2019: The Report Gamma Knife Market Analysis By Indication (Malignant Tumors,
Benign Tumors, Vascular Disorders, Functional Disorders, Ocular Diseases), By
Region, And Segment Forecasts, 2018 - 2025
The global gamma knife market is expected to reach USD
239.2 million by 2025, according to a new report by Grand View Research, Inc.
Increasing prevalence of cancer, brain tumors, and other neurological diseases,
rising adoption of these instruments in surgery centers, growing preference for
Minimally Invasive Surgeries (MIS), and technological advancements in the
device are amongst few factors expected to drive the market.
Gamma knife therapy is
used for treatment of various brain and neurological disorders such as brain
tumors, brain metastases, epilepsy, and arteriovenous malformations. Demand for
these instruments in surgery centers is growing due to their various advantages
such as safety, micro precision, lack of postsurgical complications, and lack
of incisions.
Technological
advancements have improved precision in surgery. For instance, upgradation of
Leksell Gamma Knife models U, B, C/4C, and Perfexion to Icon provided micro
precision in surgery and boosted adoption of this device in surgery centers.
According to reports published by Elekta AB, approximately 70,000 patients
undergo gamma knife surgery each year. This number is expected to increase over
the forecast period owing to rising prevalence of target diseases and increasing
preference for MIS.
In addition, growing
demand for MIS over open surgeries is one of the key factors responsible for
increasing adoption of this therapy. Gamma knife treatment procedure results in
fewer traumas and faster recovery as compared to open surgeries. It helps
reduce hospital stays, thus ensuring economic viability and reduction in
medical expenses. Lack of incisions and postsurgical complications are key
factors responsible for boosting demand for minimally invasive surgeries.
Access Research Report of Gamma
Knife Market@ www.grandviewresearch.com/industry-analysis/gamma-knife-market
Further Key Findings From the Report Suggest:
· Global gamma knife market size was
estimated at USD 171,505.7 thousandin 2016 and is expected to grow at a CAGR of
around 3% from 2017 to 2025
· Malignant tumors emerged as the largest
segment and the ocular diseases segment is anticipated to witness fastest
growth over the next 8 years
· The Asia Pacific region is anticipated to
witness lucrative growth over the next decade owing to rising incidence of
cancer, developments in healthcare infrastructure, and rapid economic
development across major emerging economies. It is expected to grow at a CAGR
of around 4% over the forecast period
· Elekta AB is the only player operating in
this market since Gamma Knife is a patent-protected trademark product of the
company.
Browse more reports of this category by Grand View
Research at: www.grandviewresearch.com/industry/medical-devices
Grand View Research has
segmented the gamma knife market on the basis of indications and region:
Gamma Knife Indications Outlook (Revenue, USD Thousand,
2014 - 2025)
·
Malignant tumors
·
Benign tumors
·
Vascular disorders
·
Functional disorders
·
Ocular diseases
Gamma Knife Regional Outlook (Revenue, USD Thousand, 2014
- 2025)
·
North America
·
Europe
·
Asia Pacific
·
Latin America
·
Middle East & Africa
Access Press Release of
Gamma Knife Market@ www.grandviewresearch.com/press-release/global-gamma-knife-market
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides
syndicated research reports, customized research reports, and consulting
services. To help clients make informed business decisions, we offer market
intelligence studies ensuring relevant and fact-based research across a range
of industries, from technology to chemicals, materials and healthcare.
No comments:
Post a Comment